Jeffrey T L Smith insider trades

Open-market stock purchases and sales by Jeffrey T L Smith, EVP & Chief Medical Officer at Zymeworks Inc, from SEC Form 4 filings since May 7, 2014.

Recent trades

DateStockTradeValue
Jan 12, 2026ZYME Zymeworks IncSold$211K
Jan 12, 2026ZYME Zymeworks IncBought (not open market)—
Jan 5, 2026ZYME Zymeworks IncSold$264K
Jan 5, 2026ZYME Zymeworks IncBought (not open market)—

Companies traded

  • ZYME Zymeworks Inc: 3 sales, last Jan 12, 2026
  • ALDR Alder Biopharmaceuticals Inc: 45 sales, last Oct 22, 2019

Get free alerts when Jeffrey T L Smith files a new trade →